Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_assertion type Assertion NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_head.
- NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_assertion description "[Gene profiling studies on chronic lymphocytic leukaemia (CLL) are at the origin of new prognosis markers such as zeta-associated protein-70 (ZAP-70), LPL and CLLU1, which, at present, are under study for their application to clinical practice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_provenance.
- NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_assertion evidence source_evidence_literature NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_provenance.
- NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_assertion SIO_000772 19698929 NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_provenance.
- NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_assertion wasDerivedFrom befree-20150227 NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_provenance.
- NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_assertion wasGeneratedBy ECO_0000203 NP539319.RAfRlK4YJoj6R_8NyFeHBhTBr1IT0QKPGC7LcCww4eEUI130_provenance.